TATX-112

N/A

Report date: 2024/01/02 16:01:40

Base Information

Drug NameTATX-112
Drug Alias NameTATX-112
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Neurotrophic tyrosine kinase receptor type 2
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesTalem Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A